Robert Wild to Female
This is a "connection" page, showing publications Robert Wild has written about Female.
Connection Strength
2.472
-
Short cycles: more menopause symptoms during transition. Menopause. 2022 10 01; 29(10):1121-1122.
Score: 0.066
-
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI. J Clin Lipidol. 2022 Jul-Aug; 16(4):483-490.
Score: 0.065
-
A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome. J Womens Health (Larchmt). 2022 06; 31(6):751-752.
Score: 0.064
-
The natural history of polycystic ovary syndrome: commentary on a longitudinal study evaluating changes in phenotype with age. Fertil Steril. 2022 05; 117(5):1067-1068.
Score: 0.064
-
Hyperlipidemia and risk for preclampsia. J Clin Lipidol. 2022 May-Jun; 16(3):253-260.
Score: 0.063
-
Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS). Menopause. 2021 07 26; 28(10):1108-1116.
Score: 0.061
-
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
Score: 0.060
-
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol. 2021 May-Jun; 15(3):423-430.
Score: 0.060
-
Role of Lipid Management in Women's Health Preventive Care. Obstet Gynecol Clin North Am. 2021 Mar; 48(1):173-191.
Score: 0.059
-
Thyroid autoantibodies: to treat or not to treat? Fertil Steril. 2020 12; 114(6):1185-1186.
Score: 0.058
-
Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome? Fertil Steril. 2020 01; 113(1):87-88.
Score: 0.055
-
Clinical utility of ovarian-stimulation intrauterine insemination. Fertil Steril. 2018 05; 109(5):795-796.
Score: 0.049
-
JCL roundtable: Managing lipid disorders in young women. J Clin Lipidol. 2016 Sep-Oct; 10(5):1058-66.
Score: 0.043
-
The risks of statin use in pregnancy: A systematic review. J Clin Lipidol. 2016 Sep-Oct; 10(5):1081-90.
Score: 0.043
-
Dyslipidemia in pregnancy. Cardiol Clin. 2015 May; 33(2):209-15.
Score: 0.040
-
Women's Health Considerations for Lipid Management. Cardiol Clin. 2015 May; 33(2):217-31.
Score: 0.040
-
Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions. Semin Reprod Med. 2014 Nov; 32(6):433-7.
Score: 0.038
-
Clinical intervention to reduce central obesity and menopausal symptoms in women aged 35 to 55 years. Menopause. 2014 Sep; 21(9):975-81.
Score: 0.038
-
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
Score: 0.034
-
Does age affect visualization of the levator ani in nulliparous women? Int Urogynecol J. 2013 Sep; 24(9):1507-13.
Score: 0.034
-
Randomized trial comparing office flexible to rigid cystoscopy in women. Int Urogynecol J. 2012 Nov; 23(11):1625-30.
Score: 0.032
-
Atherosclerotic burden during the menopausal transition is a wakeup call. Menopause. 2012 Jan; 19(1):1-2.
Score: 0.031
-
Dyslipidemia in PCOS. Steroids. 2012 Mar 10; 77(4):295-9.
Score: 0.031
-
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012 Jan; 97(1):225-30.e2.
Score: 0.031
-
Overlapping compared with end-to-end repair of third- and fourth-degree obstetric anal sphincter tears: a randomized controlled trial. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):409.
Score: 0.029
-
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011 Mar 01; 95(3):1073-9.e1-11.
Score: 0.029
-
Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011 Jan; 117(1):145-152.
Score: 0.029
-
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May; 95(5):2038-49.
Score: 0.028
-
Intrauterine tobacco exposure may alter auditory brainstem responses in newborns. Acta Obstet Gynecol Scand. 2010; 89(4):592-596.
Score: 0.027
-
Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Semin Reprod Med. 2009 Jul; 27(4):299-305.
Score: 0.026
-
The need for evidence-based medicine to be integrated into clinical practice: role of the North American Menopause Society. Menopause. 2009 May-Jun; 16(3):438-41.
Score: 0.026
-
Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint. Am J Obstet Gynecol. 2008 Jan; 198(1):4-6.
Score: 0.024
-
Endogenous androgens and cardiovascular risk. Menopause. 2007 Jul-Aug; 14(4):609-10.
Score: 0.023
-
Options for hormone therapy in women who have had a hysterectomy. Menopause. 2007 May-Jun; 14(3 Pt 2):592-7; quiz 598-9.
Score: 0.023
-
Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clin Obstet Gynecol. 2007 Mar; 50(1):226-43.
Score: 0.022
-
Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Jul; 90(7):4112-4.
Score: 0.020
-
Intergenerational Occurrence of Premature Birth and Reproductive Health in Prematurely-Born Women in the Women's Health Initiative. Matern Child Health J. 2024 Oct; 28(10):1793-1811.
Score: 0.019
-
The association between reproductive history and abdominal adipose tissue among postmenopausal women: results from the Women's Health Initiative. Hum Reprod. 2024 Aug 01; 39(8):1804-1815.
Score: 0.019
-
The effect of improved metabolic syndrome parameters on live birth. Fertil Steril. 2024 Aug; 122(2):373-375.
Score: 0.018
-
Association of maternal birth weight and maternal preterm birth with subsequent risk for adverse reproductive outcomes: The Women's Health Initiative. Early Hum Dev. 2023 09; 184:105839.
Score: 0.018
-
Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index. J Am Heart Assoc. 2023 06 20; 12(12):e029111.
Score: 0.017
-
Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88(3):1048-54.
Score: 0.017
-
Association of Preterm Birth With Prevalent and Incident Hypertension, Early-Onset Hypertension, and Cardiovascular Disease in the Women's Health Initiative. Am J Cardiol. 2023 04 01; 192:132-138.
Score: 0.017
-
Longitudinal patterns of abdominal visceral and subcutaneous adipose tissue, total body composition, and anthropometric measures in postmenopausal women: Results from the Women's Health Initiative. Int J Obes (Lond). 2023 Apr; 47(4):288-296.
Score: 0.017
-
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
Score: 0.017
-
The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort. Menopause. 2022 Dec 01; 29(12):1365-1374.
Score: 0.017
-
Blood Pressure Variability and Heart Failure Hospitalization: Results From the Women's Health Initiative. Am J Prev Med. 2022 09; 63(3):410-418.
Score: 0.016
-
Long-term health consequences of PCOS. Hum Reprod Update. 2002 May-Jun; 8(3):231-41.
Score: 0.016
-
Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative. Fertil Steril. 2022 05; 117(5):1038-1046.
Score: 0.016
-
Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study. Cancer Prev Res (Phila). 2022 03 01; 15(3):173-183.
Score: 0.016
-
A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertil Steril. 2022 02; 117(2):408-418.
Score: 0.016
-
Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 2022 02; 11(4):1145-1159.
Score: 0.016
-
Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial. PLoS Med. 2022 01; 19(1):e1003883.
Score: 0.016
-
Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol. 2002 Jan; 186(1):35-43.
Score: 0.016
-
Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. Diabetes Care. 2022 01 01; 45(1):222-231.
Score: 0.016
-
Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative. JAMA Netw Open. 2021 12 01; 4(12):e2138071.
Score: 0.016
-
Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):97-107.
Score: 0.015
-
Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2018-2029.
Score: 0.015
-
Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial. JAMA. 2021 08 03; 326(5):390-400.
Score: 0.015
-
Androgens and syndrome X. Menopause. 2001 Jul-Aug; 8(4):229.
Score: 0.015
-
Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome. Am J Obstet Gynecol. 2021 09; 225(3):280.e1-280.e11.
Score: 0.015
-
Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women. Am J Clin Nutr. 2021 04 06; 113(4):948-959.
Score: 0.015
-
Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree. Am J Obstet Gynecol. 2001 Apr; 184(5):1031-9.
Score: 0.015
-
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative. Cancer. 2021 05 15; 127(10):1658-1667.
Score: 0.015
-
The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial. Menopause. 2020 11; 27(11):1265-1273.
Score: 0.014
-
The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative. Menopause. 2020 10; 27(10):1117-1125.
Score: 0.014
-
Walking Volume and Speed Are Inversely Associated With Incidence of Treated Hypertension in Postmenopausal Women. Hypertension. 2020 11; 76(5):1435-1443.
Score: 0.014
-
Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative. J Vasc Surg. 2021 04; 73(4):1245-1252.e3.
Score: 0.014
-
Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation. J Womens Health (Larchmt). 2020 09; 29(9):1150-1159.
Score: 0.014
-
Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial. Hum Reprod. 2020 06 01; 35(6):1296-1305.
Score: 0.014
-
The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertil Steril. 2020 03; 113(3):552-560.e3.
Score: 0.014
-
Associations between Serum Levels of Cholesterol and Survival to Age 90 in Postmenopausal Women. J Am Geriatr Soc. 2020 02; 68(2):288-296.
Score: 0.014
-
It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
Score: 0.014
-
The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
Score: 0.013
-
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019 09 07; 40(34):2849-2855.
Score: 0.013
-
Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population. Fertil Steril. 2019 06; 111(6):1129-1134.
Score: 0.013
-
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes Control. 2019 Apr; 30(4):355-363.
Score: 0.013
-
Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment. Hum Fertil (Camb). 2020 Dec; 23(4):239-245.
Score: 0.013
-
Risk factors: assessment and preventive measures. Clin Obstet Gynecol. 1998 Dec; 41(4):966-75.
Score: 0.013
-
Lipids and Women's Health: Recent Updates and Implications for Practice. J Womens Health (Larchmt). 2019 06; 28(6):752-760.
Score: 0.012
-
Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility. J Clin Endocrinol Metab. 2018 07 01; 103(7):2743-2751.
Score: 0.012
-
Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):105-10.
Score: 0.011
-
Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. Fertil Steril. 2017 Mar; 107(3):756-762.e3.
Score: 0.011
-
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016 Jul-Aug; 10(4):833-841.
Score: 0.011
-
Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertil Steril. 2016 Jun; 105(6):1575-1583.e2.
Score: 0.010
-
Estrogen: effects on the cardiovascular tree. Obstet Gynecol. 1996 Feb; 87(2 Suppl):27S-35S.
Score: 0.010
-
Hormone replacement: effects on atherogenesis. Semin Reprod Endocrinol. 1996 Feb; 14(1):63-9.
Score: 0.010
-
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-122.e1.
Score: 0.010
-
Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995 Jan 16; 98(1A):27S-32S.
Score: 0.010
-
The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):1-13.
Score: 0.010
-
In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol. 2014 Nov 28; 12:119.
Score: 0.010
-
Role of endogenous estrogen in the hirsutism paradigm. J Reprod Med. 1994 Apr; 39(4):273-6.
Score: 0.009
-
The gynecologist and cardiovascular disease: a window of opportunity for prevention. J Soc Gynecol Investig. 1994 Apr-Jun; 1(2):107-17.
Score: 0.009
-
Matriarchal model for cardiovascular prevention. Obstet Gynecol Surv. 1994 Feb; 49(2):147-52.
Score: 0.009
-
Whole endometrial fragments form characteristics of in vivo endometriosis in a mesothelial cell co-culture system: an in vitro model for the study of the histogenesis of endometriosis. J Soc Gynecol Investig. 1994 Jan-Mar; 1(1):65-8.
Score: 0.009
-
Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol. 1992 Dec; 167(6):1813-8.
Score: 0.008
-
Detection of antiendometrial antibodies in patients with endometriosis: methodological issues. Fertil Steril. 1992 Sep; 58(3):518-21.
Score: 0.008
-
Evaluation of endometrial tissue specific complement activation in women with endometriosis. Fertil Steril. 1992 Apr; 57(4):787-95.
Score: 0.008
-
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol. 1992 Apr; 166(4):1191-6; discussion 1196-7.
Score: 0.008
-
Hyperandrogenism in the adolescent. Obstet Gynecol Clin North Am. 1992 Mar; 19(1):71-89.
Score: 0.008
-
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan; 97(1):28-38.e25.
Score: 0.008
-
Lipid metabolism and hyperandrogenism. Clin Obstet Gynecol. 1991 Dec; 34(4):864-71.
Score: 0.008
-
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Mar-Apr; 18(2):112-26.
Score: 0.008
-
Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception. 1991 Aug; 44(2):113-24.
Score: 0.008
-
Autoantibodies associated with endometriosis: can their detection predict presence of the disease? Obstet Gynecol. 1991 Jun; 77(6):927-31.
Score: 0.008
-
Endometrial antibodies versus CA-125 for the detection of endometriosis. Fertil Steril. 1991 Jan; 55(1):90-4.
Score: 0.007
-
Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin Endocrinol (Oxf). 2011 Jan; 74(1):89-96.
Score: 0.007
-
Evidence of heterogeneous mechanisms in lipoprotein lipid alterations in hyperandrogenic women. Am J Obstet Gynecol. 1990 Dec; 163(6 Pt 1):1998-2005.
Score: 0.007
-
Maternal diabetes and renal agenesis/dysgenesis. Birth Defects Res A Clin Mol Teratol. 2010 Sep; 88(9):722-7.
Score: 0.007
-
Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990 Aug; 54(2):255-9.
Score: 0.007
-
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010 Jul-Aug; 16(4):347-63.
Score: 0.007
-
Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 1990 Feb; 36(2):283-9.
Score: 0.007
-
The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am J Obstet Gynecol. 1988 Aug; 159(2):423-7.
Score: 0.006
-
Declining adrenal androgens: an association with bone loss in aging women. Proc Soc Exp Biol Med. 1987 Dec; 186(3):355-60.
Score: 0.006
-
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985 Nov; 61(5):946-51.
Score: 0.005
-
Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study. J Womens Health (Larchmt). 2004 Mar; 13(2):155-63.
Score: 0.005
-
Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab. 1982 Apr; 54(4):676-81.
Score: 0.004
-
The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. Diabetes Care. 2002 Mar; 25(3):500-4.
Score: 0.004
-
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2000 Jan; 85(1):214-8.
Score: 0.003
-
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998 May 13; 279(18):1445-51.
Score: 0.003
-
Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group. Climacteric. 1998 Mar; 1(1):26-32.
Score: 0.003
-
Antibodies to carbonic anhydrase in endometriosis: prevalence, specificity, and relationship to clinical and laboratory parameters. Fertil Steril. 1996 Oct; 66(4):547-56.
Score: 0.003
-
Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol. 1994 Dec; 84(6):987-95.
Score: 0.002
-
Antigenic similarities between respiratory and reproductive tract mucins: heterogeneity of mucin expression by human endocervix and endometrium. Fertil Steril. 1993 Dec; 60(6):1011-9.
Score: 0.002
-
Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril. 1993 Jun; 59(6):1196-201.
Score: 0.002
-
Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993 Mar; 59(3):583-6.
Score: 0.002
-
Effects of peritoneal macrophages from patients with endometriosis on the proliferation of endometrial carcinoma cell line ECC-1. Am J Obstet Gynecol. 1991 Dec; 165(6 Pt 1):1842-6.
Score: 0.002